We are live on ! Find out more
CLAA.WS

Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS

Delisted

CLAA.WS was delisted on the 10th of March, 2023.

41 hedge funds and large institutions have $2.65M invested in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less funds holding

Funds holding: 42 → 41 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

29% less capital invested

Capital invested by funds: $3.74M → $2.65M (-$1.09M)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
6
Closed
6
Calls
$1.34M
Puts
–
Net Calls
+$1.34M
Net Calls Change
-$129K

CLAA.WS Hedge Fund Activity: Q1 2022 in Review

41 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) for Q1 2022, worth a combined $2.65M — down 29% from $3.74M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CLAA.WS and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 1 added.

The largest buyer was Sage Rock Capital Management, opening a new position worth an estimated $38.4K. The largest seller was Security Benefit Life Insurance Company, exiting entirely with an estimated $71K sold.

  • 41 institutional investors held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) as of Q1 2022, down from 42 in Q4 2021.
  • Funds reported $2.65M of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share stock for Q1 2022, down 29% quarter-over-quarter.
  • 5 funds opened new Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share positions in Q1 2022 and 6 closed out, a net change of -1 holder.
  • The largest Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share buyer in Q1 2022 was Sage Rock Capital Management, an estimated $38.4K added.
  • The largest Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share seller in Q1 2022 was Security Benefit Life Insurance Company, an estimated $71K sold.

Based on aggregated 13F filings for Q1 2022.